Cargando…
Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial
SIMPLE SUMMARY: Most patients with HPV associated squamous cell carcinoma of the head and neck, treated with chemoradiotherapy, CRT, for cure, and who succumb to their disease, do so because of distant metastases. Even if a local recurrence as first site of treatment failure is rather low in this di...
Autores principales: | Mercke, Claes, Wickart-Johansson, Gun, Sjödin, Helena, Farrajota Neves da Silva, Pedro, Alexandersson von Döbeln, Gabriella, Margolin, Gregori, Jonmarker Jaraj, Sara, Carstens, Hanna, Berglund, Anders, Lax, Ingmar, Hellström, Mats, Hammarstedt-Nordenvall, Lalle, Friesland, Signe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177265/ https://www.ncbi.nlm.nih.gov/pubmed/37174008 http://dx.doi.org/10.3390/cancers15092543 |
Ejemplares similares
-
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects
por: Embring, Anna, et al.
Publicado: (2023) -
Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023) -
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
por: Onjukka, Eva, et al.
Publicado: (2020) -
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
por: Gebre-Medhin, Maria, et al.
Publicado: (2021) -
Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
por: Embring, Anna, et al.
Publicado: (2020)